Mr. Marek Cmero
Honorary
The Sir Peter MacCallum Department of Oncology
17 Scholarly works
0 Projects
HIGHLIGHTS
2021
Journal article
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
DOI: 10.1016/j.cell.2021.03.0092020
Journal article
Sex differences in oncogenic mutational processes
DOI: 10.1038/s41467-020-17359-22020
Journal article
MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data
DOI: 10.1101/2020.06.03.1315322020
Journal article
Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone
DOI: 10.15252/embr.2020501622020
Conference Proceedings
Loss of SNAI2 in prostate cancer and effect on patient response to androgen deprivation therapy.
DOI: 10.1200/jco.2020.38.6_suppl.3382020
Journal article
The evolutionary history of 2,658 cancers
DOI: 10.1038/s41586-019-1907-72020
Journal article
Pan-cancer analysis of whole genomes
DOI: 10.1038/s41586-020-1969-6
RECENT SCHOLARLY WORKS
2020
Journal article
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
DOI: 10.1038/s41467-020-14352-72020
Journal article
Inferring structural variant cancer cell fraction
DOI: 10.1038/s41467-020-14351-82020
Journal article
A community effort to create standards for evaluating tumor subclonal reconstruction
DOI: 10.1038/s41587-019-0364-z2019
Journal article
Using equivalence class counts for fast and accurate testing of differential transcript usage
DOI: 10.12688/f1000research.18276.22019
Journal article
Fast and accurate differential transcript usage by testing equivalence class counts [version 1; peer review: 3 approved with reservations]
DOI: 10.12688/F1000RESEARCH.18276.12016
Journal article
Comparing nodal versus bony metastatic spread using tumour phylogenies
DOI: 10.1038/srep339182016
Journal article
Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression
DOI: 10.18632/oncotarget.89152016
Journal article
A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance
DOI: 10.1038/bjc.2015.472